This story was first published in digitalhealth.net

Some NHS cancer patients are set to see reduced drug treatment times, thanks to the roll out of an anti-cancer injection that only takes seven minutes to administer.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the jab and the NHS is set to become the first health service in the world to use it.
Currently, patients receive the life-extending immunotherapy atezolizumab (Tencentriq®) in hospital directly into their veins via a drug transfusion. This usually takes around 30 minutes to administer, though can take up to an hour when it is difficult to access a vein.
It is expected that the majority of the approximately 3,600 patients starting treatment of atezolizumab annually in England will switch to the injection. However, where patients are receiving intravenous chemotherapy in combination with atezolizumab, they may remain on the transfusion.
The new treatment will not cost the NHS any more, thanks to the existing commercial deal negotiated between NHS England and the manufacturer Roche.
NHS national director for cancer Professor Peter Johnson said: “The world-first introduction of this treatment will mean that hundreds of patients can spend less time at the hospital and will free up valuable time in NHS chemotherapy units.
“Maintaining the best possible quality of life for cancer patients is vital, so the introduction of faster under-the-skin injections will make an important difference.
“Today’s announcement is the latest in a series in the 75th year of the NHS that highlights how an innovation-driven health service is securing the most advanced cancer treatments for patients.”
Dr Alexander Martin, a consultant oncologist at West Suffolk NHS Foundation Trust said: “This is great news for both patients and clinicians. We welcome any new initiative that brings speedier treatment to patients and gives them more comfortable care.
“This approval will not only allow us to deliver convenient and faster care for our patients, but will enable our teams to treat more patients throughout the day.”
Image by Memed_Nurrohmad from Pixabay
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly